Amended Statement of Beneficial Ownership (3/a)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Moore Michael

2. Date of Event Requiring Statement (MM/DD/YYYY) 12/31/2020

3. Issuer Name and Ticker or Trading Symbol

VIEMED HEALTHCARE, INC. [VMD]

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
President /

(Street)

LAFAYETTE, LA 70508

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)
12/31/2020

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Phantom Share Units ⁽¹⁾	⁽²⁾	5/9/2021	Common Shares	58088.0	$0.0 ⁽³⁾	D
Phantom Share Units ⁽¹⁾	⁽⁴⁾	5/9/2022	Common Shares	7704.0	$0.0 ⁽³⁾	D
Phantom Share Units ⁽¹⁾	⁽⁵⁾	5/9/2023	Common Shares	9392.0	$0.0 ⁽³⁾	D

Explanation of Responses:
(1)	The original Form 3 filed on December 31, 2020 is being amended by this Form 3/A solely to include Phantom Share Units held by the reporting person that were unintentionally omitted.
(2)	Represents an award granted in 2018 under the Issuer's Phantom Share Unit Plan which vests on May 9, 2021, subject to the Reporting Person's continued employment with the Issuer on such vesting date.
(3)	Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common stock which will be determined based on the Issuer's share price on the vesting date.
(4)	Represents an award granted in 2019 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2021 and May 9, 2022, subject to the Reporting Person's continued employment with the Issuer on such vesting date.
(5)	Represents an award granted in 2020 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2021, May 9, 2022, and May 9, 2023, subject to the Reporting Person's continued employment with the Issuer on such vesting date.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Moore Michael 625 E. KALISTE SALOOM RD. LAFAYETTE, LA 70508			President